Flexion Therapeutics, Inc.
10 Mall Road, Suite 301
Burlington, MA 01803
September 16, 2020
Via EDGAR
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attn: Courtney Lindsay
RE: | Flexion Therapeutics, Inc. |
Registration Statement on Form S-3
File No. 333-248749
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 4:00 p.m. Eastern Time on September 18, 2020, or as soon thereafter as is practicable.
Thank you for your assistance. If you should have any questions, please contact Sean Clayton of Cooley LLP, counsel to the Registrant, at (858) 550-6034.
Flexion Therapeutics, inc.
By: /s/ Mark Levine
Mark Levine
General Counsel
